Study highlights need for interventions to improve statin use among older adults

NewsGuard 100/100 Score

In a British Journal of Clinical Pharmacology study of older adults prescribed statins, first-year nonadherence and discontinuation rates were high.

Among 22,340 Australians aged ≥65 years who initiated statin therapy from 2014 to 2015, 55.1% were nonadherent (did not take statins for at least 80% of the intended time) in the first year after receiving their prescription, and 44.7% had discontinued altogether. Age ≥85 years, diabetes, anxiety, and being initiated on statins by a general practitioner (as opposed to a specialist) were associated with higher likelihood of nonadherence and discontinuation, while hypertension, angina, congestive heart failure, and polypharmacy (concurrent use of ≥5 drugs) were associated with a lower likelihood of nonadherence and discontinuation.

“The study findings highlight the need for interventions to improve statin use among older adults—in order that the benefits of statins can be realized—and recognition that certain sub-groups of people may require additional attention,” said senior author Professor Danny Liew, of Monash University, in Australia.

Source: https://newsroom.wiley.com/press-release/british-journal-clinical-pharmacology/many-older-adults-do-not-take-prescribed-statins

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Non-invasive detection and treatment of ovarian cancer with new radiotheranostic system